Stellate Ganglion Block

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity of Minnesota

About this trial

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

Eligibility criteria

Qualifiers

Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.

Disqualifiers

Patients who have an exclusion to regional anesthesia.

Patients who have exclusion to stellate blockade.

Patients who are pregnant assessed via self-report or pregnancy test if they have taken one

Trial design

Treatments tested in this trial

  • 0.5% bupivacaine
  • Saline

Treatment groups

48 Participants
are divided into 2 treatment groups

Sponsors and collaborators